The cockroach allergen–induced asthma mouse model was established with the protocol as illustrated in Figure 1A. Briefly, mice were sensitized by intra-tracheal (i.t.) inhalation of 20 µg of cockroach extract (CRE, B46, GREER Laboratories) per mouse in 50 μl of Phosphate-Buffered Saline (PBS) under light anesthesia with isoflurane and challenged with the same amount of CRE. Control mice were treated with PBS. Mice were sacrificed, and samples [lung tissues, bronchoalveolar lavage fluid (BALF), and blood] were collected on the next day after the last allergen challenge (30 (link)). In particular, BALF was harvested by two consecutive flushes of the lung with 1.0 ml of ice-cold PBS. Blood was taken to screen for serum antibodies against cockroach allergen. In some cases, mice were pre-treated with autophagy inhibitor chloroquine (CLQ; C6628, 60 mg/kg, Sigma-Aldrich, St. Louis, MO, USA) or saline vehicle control by intraperitoneal administration 1 h before every single allergen challenge.
Free full text: Click here